| Serial Number | 87771644 |
| Word Mark | CRI |
| Filing Date | Friday, January 26, 2018 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Friday, April 1, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Providing online non-downloadable electronic publications in the nature of newsletters, journals, and books in the field of cannabinoid-based medicines; arranging, conducting and organisation of educational conferences, congresses, seminars and symposiums in the field of cannabinoid-based medicines; information, advisory and consultancy services in relation to all of the aforesaid services |
| Goods and Services | Financing services; providing funding for investigators, inventors, universities, research institutes and other academic entities, namely, financing services and providing venture capital, development capital, private equity and investment funding; funding of research and product development, namely, financing services and providing venture capital, development capital, private equity and investment funding; information, advisory and consultancy services in relation to all of the aforesaid services |
| Goods and Services | Scientific and technological services and research and design relating thereto, namely, scientific research in the field of cannabinoid-based medicines, research on the subject of pharmaceuticals, and pharmaceutical drug development services, all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical research and development services all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; research, testing and development of pharmaceutical and veterinary preparations all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; biological, clinical and medical research all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; conducting clinical trials for others all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; chemical analysis all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; information, advisory and consultancy services in relation to all of the aforesaid services |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 7, 2018 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 7, 2018 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 7, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | GW RESEARCH LIMITED |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 99 - Other |
| Address | CAMBRIDGE CB249BZ GB |
| Party Name | GW Pharma Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Cambridge CB249BZ GB |
| Event Date | Event Description |
| Friday, April 1, 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Friday, April 1, 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, September 15, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 15, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, September 15, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, September 15, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, September 15, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 15, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 15, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 18, 2021 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Wednesday, July 28, 2021 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Monday, November 23, 2020 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, May 6, 2020 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Monday, April 20, 2020 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Friday, October 11, 2019 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, April 17, 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, April 11, 2019 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, April 11, 2019 | LETTER OF SUSPENSION E-MAILED |
| Thursday, April 11, 2019 | SUSPENSION LETTER WRITTEN |
| Monday, March 11, 2019 | ASSIGNED TO EXAMINER |
| Monday, February 11, 2019 | ASSIGNED TO EXAMINER |
| Tuesday, February 5, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 5, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 28, 2019 | ASSIGNED TO LIE |
| Monday, January 21, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 23, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, July 23, 2018 | NON-FINAL ACTION E-MAILED |
| Monday, July 23, 2018 | NON-FINAL ACTION WRITTEN |
| Monday, July 23, 2018 | ASSIGNED TO EXAMINER |
| Thursday, May 10, 2018 | ASSIGNED TO EXAMINER |
| Wednesday, May 9, 2018 | ASSIGNED TO EXAMINER |
| Wednesday, February 7, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 30, 2018 | NEW APPLICATION ENTERED |